ISSN# 1545-4428 | Published date: 19 April, 2024
You must be logged in to view entire program, abstracts, and syllabi
At-A-Glance Session Detail
   
2016-2024: The Evolution of Ideas from Singapore 2016
Weekday Course
ORGANIZERS: Akshay Chaudhari, Brian Hargreaves
Thursday, 09 May 2024
Room 334-336
16:00 -  18:00
Moderators: Akshay Chaudhari & James Pipe
Session Number: Th-05
CME Credit

Session Number: Th-05

Overview
ISMRM has returned to Singapore after 8 years! This session takes us back to revisit some of the emerging or hot topics from 2016. How have they progressed? What has gone well, and what are the limitations or unsolved areas? Where are these headed in the future? What can we learn for future health innovations?


Target Audience
Presentations are targeted to very broad technical and clinical audiences within the ISMRM. Presenters are asked to keep the talks at a high level, with a broad and critical analysis of the area, including some examples. References may be made to current literature, including work presented at the 2024 ISMRM.

Educational Objectives
As a result of attending this course, participants should be able to:
-Review the high-level history of the broad topics that began in Singapore 2016, and what progress has been made; and
-Explore topics in more depth and apply principles in their own research and/or clinical practices.

16:00 Successes, Failures & Directions for Deep Learning & AI in MR Image Acquisition/Reconstruction
Jonathan Tamir
16:25 The MR Value Initiative: Progress since 2016
Yoshimi Anzai
In this presentation, we will discuss the progress made on the MR Value initiative ignited in 2016, in part due to the increasing pressure to contain the costs of “expensive technology” such as MRI. The COVID-19 pandemic accelerated some of the progress in the last several years. In this presentation, we will discuss past progress, current challenges, and future directions. 
16:50 Population Neuroimaging: An Awfully Big Adventure
Karla Miller
17:15 Quantitative MRI & Biomarkers: What Has Worked? What Has Not?
Vikas Gulani
17:40 Discussion